ATM and B-cell chronic lymphocytic leukemia: ATM-mutated CLL (low ID3) define a sub-group of patients with an unfavourable clinical course [43] and IGHV-mutated CLL (high ID3) define a more favourable prognostic sub-group (reviewed in [44]).